Tumour mutations trang 1 tải miễn phí từ tailieunhanh

"Tumour mutations" trang 1 - tải miễn phí từ tailieunhanh

The impact of KRAS mutations on VEGF-A production and tumour vascular network

The impact of KRAS mutations on VEGF-A production and tumour vascular network

11 44 1

Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content

Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content

13 60 3

SomInaClust: Detection of cancer genes based on somatic mutation patterns of inactivation and clustering

SomInaClust: Detection of cancer genes based on somatic mutation patterns of inactivation and clustering

12 43 1

ICECREAM: Randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours

ICECREAM: Randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours

8 67 1

Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment, for the BRAF EQA group

Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment, for the BRAF EQA group

6 39 1

Involvement of mutant and wild-type CYSL TR2 in the development and progression of uveal nevi and melanoma

Involvement of mutant and wild-type CYSL TR2 in the development and progression of uveal nevi and melanoma

12 26 1

Association of emergence of new mutations in circulating tumuor DNA during chemotherapy with clinical outcome in metastatic colorectal cancer

Association of emergence of new mutations in circulating tumuor DNA during chemotherapy with clinical outcome in metastatic colorectal cancer

10 52 1

The secondary KIT mutation p.Ala510Val in a cutaneous mast cell tumour carrying the activating mutation p.Asn508Ile confers resistance to masitinib in dogs

The secondary KIT mutation p.Ala510Val in a cutaneous mast cell tumour carrying the activating mutation p.Asn508Ile confers resistance to masitinib in dogs

9 22 1

Regulatory single nucleotide polymorphisms (rSNPs) at the promoters 1A and 1B of the human APC gene

Regulatory single nucleotide polymorphisms (rSNPs) at the promoters 1A and 1B of the human APC gene

9 9 1